Subtopic Deep Dive
Klotho Deficiency in Mineral Metabolism
Research Guide
What is Klotho Deficiency in Mineral Metabolism?
Klotho deficiency refers to reduced levels of soluble and membrane-bound Klotho protein, disrupting the FGF23-PTH-vitamin D axis and leading to mineral metabolism dysregulation in chronic kidney disease (CKD).
Klotho, primarily produced in the kidney, negatively regulates 1,25(OH)₂D₃ formation and phosphate homeostasis (Almilaji et al., 2014, 5605 citations). Deficiency contributes to hyperphosphatemia, vascular calcification, and CKD progression. Over 10 papers from the list link Klotho to FGF23 signaling and parathyroid function.
Why It Matters
Klotho deficiency drives vascular calcification in CKD patients via calcium-phosphate dysregulation, increasing cardiovascular mortality (Shanahan et al., 2011, 911 citations). It exacerbates FGF23 resistance, elevating PTH and preventing phosphate excretion (Ben-Dov et al., 2007, 948 citations). Therapies targeting Klotho could slow CKD progression and treat hypophosphatemia variants like XLH (Carpenter et al., 2011, 595 citations).
Key Research Challenges
Quantifying Soluble Klotho Levels
Assays for circulating Klotho vary in sensitivity, complicating deficiency diagnosis in CKD (Almilaji et al., 2014). Standardization lacks across studies. This hinders clinical correlations with mineral markers.
FGF23-Klotho Receptor Interactions
Membrane Klotho is essential for FGF23 signaling in kidney and parathyroid, but deficiency mechanisms remain unclear (Ben-Dov et al., 2007, 948 citations). Structural details of the complex are limited. Therapeutic targeting faces delivery challenges.
Vascular Calcification Pathways
Klotho deficiency promotes arterial calcification via phosphate overload, but osteocyte roles need clarification (Dallas et al., 2013, 976 citations; Shanahan et al., 2011). Human models lag animal data. Interventions lack specificity.
Essential Papers
Regulation of the Voltage Gated K<sup>+</sup> Channel K<sub>v1.3</sub> by Recombinant Human Klotho Protein
Ahmad Almilaji, Sabina Honisch, Guilai Liu et al. · 2014 · Kidney & Blood Pressure Research · 5.6K citations
<b><i>Background/Aims: </i></b>Klotho, a protein mainly produced in the kidney and released into circulating blood, contributes to the negative regulation of 1,25(OH)<sub...
The Osteocyte: An Endocrine Cell … and More
Sarah L. Dallas, Matthew Prideaux, Lynda F. Bonewald · 2013 · Endocrine Reviews · 976 citations
Few investigators think of bone as an endocrine gland, even after the discovery that osteocytes produce circulating fibroblast growth factor 23 that targets the kidney and potentially other organs....
The parathyroid is a target organ for FGF23 in rats
Iddo Z. Ben‐Dov, Hillel Galitzer, Vardit Lavi-Moshayoff et al. · 2007 · Journal of Clinical Investigation · 948 citations
Phosphate homeostasis is maintained by a counterbalance between efflux from the kidney and influx from intestine and bone. FGF23 is a bone-derived phosphaturic hormone that acts on the kidney to in...
Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate
Catherine M. Shanahan, Matthew H. Crouthamel, Alexander Kapustin et al. · 2011 · Circulation Research · 911 citations
Vascular calcification contributes to the high risk of cardiovascular mortality in chronic kidney disease (CKD) patients. Dysregulation of calcium (Ca) and phosphate (P) metabolism is common in CKD...
Fibroblast Growth Factor 23 and Hypophosphatemia: A Case of Hypophosphatemia along the Rickets-Osteomalacia Spectrum
George T. Georges, O. Nájera, Kurt Sowers et al. · 2016 · Cardiorenal Medicine · 682 citations
Phosphorus is a key component of bone, and a deficiency results in poor mineralization along with other systemic symptoms of hypophosphatemia. Various causes of hypophosphatemia with renal wasting ...
A clinician's guide to X-linked hypophosphatemia
Thomas O. Carpenter, Erik A. Imel, Ingrid A. Holm et al. · 2011 · Journal of Bone and Mineral Research · 595 citations
Abstract X-linked hypophosphatemia (XLH) is the prototypic disorder of renal phosphate wasting, and the most common form of heritable rickets. Physicians, patients, and support groups have all expr...
Peripheral arterial calcification: Prevalence, mechanism, detection, and clinical implications
Krishna J. Rocha‐Singh, Thomas Zeller, Michael R. Jaff · 2014 · Catheterization and Cardiovascular Interventions · 569 citations
Vascular calcification (VC), particularly medial (Mönckeberg's medial sclerosis) arterial calcification, is common in patients with diabetes mellitus and chronic kidney disease and is associated wi...
Reading Guide
Foundational Papers
Start with Almilaji et al. (2014, 5605 citations) for Klotho basics; Ben-Dov et al. (2007, 948 citations) for FGF23-parathyroid links; Dallas et al. (2013, 976 citations) for osteocyte roles.
Recent Advances
Xu & Sun (2015, 531 citations) on Klotho aging functions; Haffner et al. (2019, 497 citations) on XLH management relevant to hypophosphatemia.
Core Methods
Immunoassays for soluble Klotho; FGF23 binding assays; calcium-phosphate rodent models; vascular imaging for calcification.
How PapersFlow Helps You Research Klotho Deficiency in Mineral Metabolism
Discover & Search
Research Agent uses searchPapers and exaSearch to find Klotho-FGF23 papers, then citationGraph on Almilaji et al. (2014) reveals 5605 downstream citations linking to CKD mineral disorders.
Analyze & Verify
Analysis Agent applies readPaperContent to extract FGF23-PTH axis data from Ben-Dov et al. (2007), verifies claims with CoVe against Shanahan et al. (2011), and runs PythonAnalysis for meta-analysis of phosphate levels across 10 papers using GRADE for evidence strength.
Synthesize & Write
Synthesis Agent detects gaps in Klotho therapy trials via contradiction flagging, while Writing Agent uses latexEditText, latexSyncCitations for 20-paper reviews, and latexCompile to generate mineral metabolism diagrams with exportMermaid.
Use Cases
"Extract phosphate correlation data from Klotho deficiency papers and plot trends"
Research Agent → searchPapers('Klotho deficiency phosphate CKD') → Analysis Agent → readPaperContent(Almilaji 2014, Shanahan 2011) → runPythonAnalysis(pandas correlation plot, matplotlib visualization) → researcher gets CSV trends and GRADE-verified graph.
"Draft review on FGF23-Klotho in parathyroid disorders with citations"
Synthesis Agent → gap detection on Ben-Dov 2007 cluster → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile(PDF) → researcher gets compiled LaTeX review with synced bibliography.
"Find code for Klotho-FGF23 signaling simulations"
Research Agent → searchPapers('Klotho FGF23 model CKD') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets runnable Python models for mineral axis simulations.
Automated Workflows
Deep Research workflow scans 50+ Klotho papers via searchPapers → citationGraph → structured report on deficiency impacts. DeepScan applies 7-step verification: readPaperContent → CoVe → runPythonAnalysis on calcification data from Shanahan et al. Theorizer generates hypotheses on Klotho restoration from Dallas et al. (2013) osteocyte insights.
Frequently Asked Questions
What defines Klotho deficiency?
Klotho deficiency is reduced soluble/membrane Klotho suppressing FGF23 signaling, causing phosphate retention and 1,25(OH)₂D₃ dysregulation (Almilaji et al., 2014).
What methods study Klotho in mineral metabolism?
Assays measure soluble Klotho; animal models test FGF23-Klotho interactions in kidney/parathyroid; phosphate imaging tracks calcification (Ben-Dov et al., 2007; Shanahan et al., 2011).
What are key papers?
Almilaji et al. (2014, 5605 citations) on Klotho regulation; Ben-Dov et al. (2007, 948 citations) on parathyroid FGF23; Dallas et al. (2013, 976 citations) on osteocytes.
What open problems exist?
Klotho replacement therapies lack human trials; precise deficiency thresholds for CKD intervention undefined; vascular reversal mechanisms unclear (Xu & Sun, 2015).
Research Parathyroid Disorders and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Klotho Deficiency in Mineral Metabolism with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers